Equities

Elion Energy Co Ltd

Elion Energy Co Ltd

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (CNY)6.72
  • Today's Change-0.04 / -0.59%
  • Shares traded13.72m
  • 1 Year change-27.19%
  • Beta1.1001
Data delayed at least 15 minutes, as of Dec 05 2016 06:59 GMT.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

As of Dec 03, 2016, the consensus forecast amongst 4 polled investment analysts covering Elion Energy Co Ltd advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Nov 30, 2015. The previous consensus forecast advised investors to purchase equity in Elion Energy Co Ltd.
  • 1yr ago
  • 3M ago
  • 2M ago
  • 1M ago
  • Latest
Select bar for recommendation details.
RecommendationsLatest
Buy0
Outperform4
Hold0
Underperform0
Sell0

Share price forecast

The one analyst offering a 12 month price target expects Elion Energy Co Ltd share price to rise to 8.50 in the next year from the last price of 6.72.
High26.5%8.50
Med26.5%8.50
Low26.5%8.50

Dividends

Historical dividend information is not available for Elion Energy Co Ltd.
Div growth (TTM)-2.63%
More ▼

Earnings history & estimates

Elion Energy Co Ltd reported annual 2015 earnings of 0.06 per share on Apr 21, 2016.
The next earnings announcement from Elion Energy Co Ltd is expected the week of Apr 20, 2017.
Average growth rate-50.00%
More ▼

Revenue history & estimates

Inner Mongolia Elion Clean Energy Company Limited had revenues for the full year 2015 of 8.06bn. This was 32.92% below the prior year's results.
Average growth rate-32.92%
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.